Schneider CK, Melmed RD, Barstow LE, Enriquez FJ, Ranger-Moore J, Ostrem JA. Oral Human Immunoglobulin for Children with Autism and Gastrointestinal Dysfunction: A Prospective, Open-Label Study.

FORBES: Anti-Vaccine Activists Apparently Immune To Science

Announcing the failure of the latest trial Tuesday, the two companies said they would halt development of Dimebon for all indications and cease an ongoing open-label extension study in Alzheimer's disease.

WSJ: Medivation, Pfizer Alzheimer's Drug Fails to Meet Study Goals

The study was a multinational, single-arm, open-label, 78 week trial that was recently published in the November 2, 2012 online version of the Lancet.

FORBES: FDA Approves Lomitapide For Homozygous Familial Hypercholesterolemia